Rare diseases
Investigational molecules
Locations
A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
BulgariaA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
CzechiaRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
AustriaPhase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes
GermanyA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
BulgariaStudy on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes
GermanyStudy on the Effects of AZD5004 for Adults with Obesity or Overweight and a Related Medical Condition
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
